SlideServe
Menu
Préférences
© SlideServe · v2026

Neurology

minna avatar
31 diapositives · 1.1K Views · Aug 19, 2012

Neurology. Adam Couves 0606330c@student.gla.ac.uk. Today we will cover…. The two big ‘uns: Stroke Parkinson’s Disease. Aims. Past paper questions: Definitions Aetiology Clinical pictures Differential diagnoses Management Complications. Stroke.

Neurology - slide 1
01 / 31Neurology
1 / 17

Télécharger la présentation

Neurology
Une image / un lien ci-dessous est fourni (tel quel) pour télécharger la présentation

Politique de téléchargement : le contenu du site vous est fourni TEL QUEL pour votre information et votre usage personnel ; il ne peut être vendu, concédé sous licence ni partagé sur d’autres sites sans l’accord de son auteur.Le contenu vous est fourni TEL QUEL, pour votre information et votre usage personnel uniquement. Téléchargez la présentation en cliquant sur ce lien. Lors du téléchargement, si vous ne parvenez pas à télécharger une présentation, l’éditeur a peut-être supprimé le fichier de son serveur.Pendant le téléchargement, si vous ne parvenez pas à obtenir une présentation, le fichier a peut-être été supprimé par l’éditeur.

F I N

Plus de contenu associé

Transcription de la présentation
  1. Neurology Adam Couves 0606330c@student.gla.ac.uk

  2. Today we will cover… The two big ‘uns: • Stroke • Parkinson’s Disease

  3. Aims Past paper questions: • Definitions • Aetiology • Clinical pictures • Differential diagnoses • Management • Complications

  4. Stroke • Acute neurological deficit (usually focal) of cerebrovascular origin lasting >24 hours • <24 hours = TIA • Two types: • Ischaemic • Haemorrhagic

  5. Pathophysiology • Usually thrombotic embolus • Origins: • Heart (AF, MI) • Carotids (atherosclerosis) • Lodges distally occluding blood supply and hence ↓O2 delivery to cerebral tissue

  6. Ischaemic Cascade • Failure of ATP dependant Na+/K+ pump – depolarisation • Glutamate toxicity • Ca2+ influx into cells • Initiating wide spread destructive effects • Progressive infarction

  7. Risk Factors • Cardiac: • MI • AF • Valvular heart disease • Cheeky extra: • Previous Stroke / TIA • Atherosclerosis: • Smoking • Diabetes • Hypercholesterolaemia • Age • SE Asian heritage • Thrombosis: • Oral Contraceptive Pill • Polycythaemia • Thrombophilia • Vasculitis

  8. Clinical Picture • Related to neuroanatomy:

  9. Total Anterior Circulation Syndrome • Usually proximal MCA or ICA occlusion • Hemiparesis • Higher Cortical Dysfunction • Dysphasia • Visuospatial neglect • Homonymous Hemianopia

  10. Homonymous Hemianopia • Optic radiation runs along MCA territory

  11. Partial Anterior Circulation Syndrome • Usually branch MCA occlusion • Any 2 out of 3: • Hemiparesis • Higher Cortical Dysfunction • Dysphasia • Visuospatial neglect • Homonymous Hemianopia

  12. POsterior Circulation Syndrome • Vertebral, Basilar, Cerebellar or PCA vessels • Isolated Hemianopia (PCA) • Brainstem Syndromes • Cerebellar Syndromes

  13. LACunar Syndrome • Basal Ganglia - supplied by end arteries (lenticulostriate arteries) • Pure Motor Stroke → Internal Capsule • Pure Sensory Stroke → Thalamus • Sensorimotor Stroke • Ataxic Hemiparesis • Clumsy Hand Dysarthria

  14. Differential Diagnosis • Todd’s Paresis (post – ictal) • Bell’s Palsy / VII CN HSV infection • Cerebral Tumour • Brain Abscess • Hypoglycaemia • Encephalitis • Subdural Haematoma • Traumatic Brain Injury

  15. ACUTE MANAGEMENT • Airway • Protected • Swallowing? • Breathing • Adequate on air? • Circulation • Fluid replacement if BP ↓ • Do not routinely treat hypertension • Disablility • GCS • Pupils • Exposure • Sustained other injuries with fall? • Concomitant pathologies? • GLUCOSE!

  16. Investigations: • CT Scan: • Rule out HAEMORRHAGE • Exclude tumour • Evidence of early ischaemic changes • Bloods – FBC, U+E, Glucose, Coagulation, ESR • Cardiac • ECG • Echo • Carotid doppler US • CXR – heart size, lung pathology, tumours

  17. Thrombolysis • Administered <4.5hrs of symptom onset • Recombinant tissue Plasminogen Activator (rtPA) = “alteplase” • Binds to fibrin and activates plasminogen → cleaves fibrin → degrades thrombus • Also give Aspirin 300mg

  18. Contraindications • Extremes of age (>80 or <18) • NIHSS > 25 or NIHSS <4 • Previous severe disability / terminal illness • Hx ICH / neoplasm or AV malformation • Stroke / prev head trauma (3/12) • Platelets ↓or INR > 1.5 • Pregnancy / Recent Childbirth (2 weeks) • Recent MI (1 month) • Active Bleeding / Acute Trauma • Major Surgery (2 weeks)

  19. Complications • Dysphagia • Malnutrition / Medications • Aspiration pneumonia • Immobility • Muscle wasting and contractures • Pressure sores → ulceration → infection • Falls • Osteoporosis • Incontinence • Skin integrity • Retention of Urine • Catheterisation → UTI • Epilepsy • Depression • Death

  20. Secondary Prevention • Antiplatelet • Aspirin 300mg (2/52) then 75mg • Dipyridamole 200mg • Statin • BP (aggressive if DM) • Carotid Endarterectomy • Lifestyle

  21. Parkinson’s Disease

  22. Parkinsonism Triad of Symptoms: • Tremor • Unilateral • 4-6 Hz • Pin - rolling • Worse at rest • Rigidity • Lead pipe • Cog-wheeling • Bradykinesia • Serpentine Stare (Hypomimia) • Reduced arm swing • Reduced frequency and amplitude of repetitive movements • Worse with co-stimulation • Loss of Postural reflexes • Pull test • Difficulty turning around • Early falls

  23. Idiopathic Parkinson’s Disease • Progressive degeneration of dopaminergic neurons of nigrostriatal pathway (Subtantia Nigra → Lentiform Nucleus) • Disrupting complex feedback mechanisms involved in initiating and maintaining movement • Symptoms arise when 60-80% of neurons are lost

  24. Non-motor Symptoms • Sensory • Anosmia!! • Psychological • Depression • Obsessive and Impulsive behaviours • Dementia • Hallucinations • Sleep Disorders • Urinary Incontinence • Dysphagia and Gastro-Oesophageal reflux • Sweating and pale cool skin • Erectile dysfunction

  25. Management • Levodopa • Combined with Carbidopa (Sinemet) • Improve pharmaco-kinetic profile • Reduce side effects • Postural hypotension • Nausea • Hallucinations L-DOPA L-DOPA DOPA Dopamine

  26. Dopamine Agonists • E.g. Ropinirole, Apomorphine Agonise dopamine receptors

  27. MAOI – Selegine DOPA Dopamine 3-MT MAOI HVA 3-4-DPA

  28. COMT-I - Entacapone 3-OMD DOPA Dopamine 3-MT COMT-I

  29. Considerations for L-DOPA? • Age of patient • Disease severity • Dysphagia / Gut motility • Preparation • Protein • Side effects On / Off syndrome

  30. Differentials - Parkinsonism

  31. Akinetic Rigid Syndromes